Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains
Clinical trial NCT07436611 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07436611
- Sponsor
- AFT Pharmaceuticals, Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.